Insider Transactions in Q4 2024 at Kiniksa Pharmaceuticals, Ltd. (KNSA)
Insider Transaction List (Q4 2024)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Dec 16
2024
|
Eben Tessari CHIEF OPERATING OFFICER |
SELL
Open market or private sale
|
Direct |
23,017
-19.34%
|
$460,340
$20.44 P/Share
|
|
Dec 16
2024
|
Eben Tessari CHIEF OPERATING OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
16,017
+11.86%
|
$16,017
$1.59 P/Share
|
|
Dec 09
2024
|
Mark Ragosa CHIEF FINANCIAL OFFICER |
SELL
Open market or private sale
|
Direct |
18,860
-45.1%
|
$396,060
$21.38 P/Share
|
|
Dec 09
2024
|
Mark Ragosa CHIEF FINANCIAL OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
18,860
+31.08%
|
$207,460
$11.1 P/Share
|
|
Dec 06
2024
|
Mark Ragosa CHIEF FINANCIAL OFFICER |
SELL
Open market or private sale
|
Direct |
8,969
-28.09%
|
$188,349
$21.27 P/Share
|
|
Dec 06
2024
|
Mark Ragosa CHIEF FINANCIAL OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
2,406
+8.66%
|
$24,060
$10.76 P/Share
|
|
Dec 05
2024
|
Mark Ragosa CHIEF FINANCIAL OFFICER |
SELL
Open market or private sale
|
Direct |
1,123
-4.66%
|
$23,583
$21.25 P/Share
|
|
Dec 05
2024
|
Mark Ragosa CHIEF FINANCIAL OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
1,123
+4.46%
|
$11,230
$10.76 P/Share
|
|
Dec 04
2024
|
Mark Ragosa CHIEF FINANCIAL OFFICER |
SELL
Open market or private sale
|
Direct |
5,024
-17.95%
|
$105,504
$21.25 P/Share
|
|
Dec 04
2024
|
Mark Ragosa CHIEF FINANCIAL OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
5,024
+15.22%
|
$50,240
$10.76 P/Share
|
|
Dec 03
2024
|
Mark Ragosa CHIEF FINANCIAL OFFICER |
SELL
Open market or private sale
|
Direct |
8,969
-28.09%
|
$188,349
$21.45 P/Share
|
|
Dec 03
2024
|
Mark Ragosa CHIEF FINANCIAL OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
8,969
+21.93%
|
$89,690
$10.76 P/Share
|
|
Nov 29
2024
|
Michael R Megna CHIEF ACCOUNTING OFFICER |
SELL
Open market or private sale
|
Direct |
9
-0.03%
|
$198
$22.45 P/Share
|
|
Nov 29
2024
|
Michael R Megna CHIEF ACCOUNTING OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
9
+0.03%
|
$99
$11.1 P/Share
|
|
Nov 27
2024
|
Michael R Megna CHIEF ACCOUNTING OFFICER |
SELL
Open market or private sale
|
Direct |
8,637
-24.56%
|
$190,014
$22.45 P/Share
|
|
Nov 27
2024
|
Michael R Megna CHIEF ACCOUNTING OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
8,637
+19.72%
|
$95,007
$11.1 P/Share
|
|
Nov 18
2024
|
Eben Tessari CHIEF OPERATING OFFICER |
SELL
Open market or private sale
|
Direct |
17,000
-14.17%
|
$357,000
$21.04 P/Share
|
|
Nov 18
2024
|
Eben Tessari CHIEF OPERATING OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
10,000
+7.69%
|
$10,000
$1.59 P/Share
|
|
Nov 07
2024
|
Richard S Levy |
BUY
Exercise of conversion of derivative security
|
Direct |
1,303
+8.4%
|
-
|
|
Nov 06
2024
|
Sanj K Patel CHAIRMAN & CEO |
SELL
Open market or private sale
|
Direct |
89,561
-52.96%
|
$2,059,903
$23.0 P/Share
|
|
Nov 06
2024
|
Sanj K Patel CHAIRMAN & CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
89,561
+34.62%
|
$89,561
$1.59 P/Share
|
|
Oct 15
2024
|
Eben Tessari CHIEF OPERATING OFFICER |
SELL
Open market or private sale
|
Direct |
17,000
-13.39%
|
$442,000
$26.87 P/Share
|
|
Oct 15
2024
|
Eben Tessari CHIEF OPERATING OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
10,000
+7.3%
|
$10,000
$1.59 P/Share
|
|
Oct 04
2024
|
Michael R Megna CHIEF ACCOUNTING OFFICER |
SELL
Payment of exercise price or tax liability
|
Direct |
82
-0.31%
|
$1,968
$24.48 P/Share
|
|
Oct 04
2024
|
Michael R Megna CHIEF ACCOUNTING OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
175
+0.65%
|
-
|
|
Oct 04
2024
|
Baker Bros. Advisors LP |
BUY
Grant, award, or other acquisition
|
Indirect |
9,460
+1.86%
|
-
|